gip and glp-1 pathways Two incretin hormones GIP: Comparison of their actions in insulin secretion and β cell preservation GLP-1 & GIP Agonists |

Antioxidants (Basel) 9, 1283

Cannot redeclare control with same name "grid_1_qv_cta_style_tab_normal"

To summarize the last article: GLP-1 medications are reshaping modern medicine because they target the gut-brain-metabolic axis that drives most chronic disease - not just weight loss, but cardiovascular disease, heart failure, kidney disease, neurodegeneration, fatty liver, and systemic inflammation

Beneficial effects have also been reported by the use of melatonin in brain-injured mice 24 h after reperfusion with a selective action involving caspases 3 inhibition 40

Additionally, ALA was well-tolerated throughout the studies, leading to a favorable dose-dependent safety profile (Table 3)

Exercise not only accelerates fat loss but helps maintain that weight loss after discontinuing medication